People with Cystic Fibrosis have a less rich intestinal microbiota. This is due to the frequent antibiotic treatments they have to undergo from an early age and also because of the intestinal problems caused by the pathology itself.
In this context, Oxalobacter Formigenes, a microorganism assigned exclusively to the metabolism of oxalates often fails. As a consequence, patients may face a 70 times higher risk of developing calcium oxalate urolithiasis compared with a healthy subject.
Oxalic acid also has a strong pro-inflammatory action in the intestine.
Yoxa, granulated in sachets, is a supplement based on live lactic ferments formulated to overcome the lack of the microorganism Oxalobacter Formigenes.
Yoxa contains five different bacterial strains, all selected for their peculiar ability to metabolize oxalates and for an intrinsic anti-inflammatory action.
The product must be used under prescription and medical supervision.
